Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ling Yui Holdings Limited ( (HK:0784) ) has issued an announcement.
Ling Yui Holdings Limited has jointly announced with Hapbiotech Investment Holding Limited the despatch of a composite document regarding an unconditional mandatory cash offer for all issued shares in Ling Yui not already owned or agreed to be acquired by Hapbiotech and its concert parties. The document, sent to independent shareholders on 5 May 2026, sets out the terms of the offer, the expected timetable, and the recommendations and advice from the board, the independent board committee and the independent financial adviser, marking a key step in the potential change of control and providing shareholders with guidance ahead of the 26 May 2026 closing date.
The offer period runs from 5 May 2026 to 26 May 2026, with independent shareholders able to accept the cash offer up to 4:00 p.m. on the closing date. Results of the offer are scheduled to be announced on the same day, and payment for valid acceptances is expected to be remitted by 4 June 2026, giving investors a clear timeline for decision-making and settlement amid the ongoing takeover process.
More about Ling Yui Holdings Limited
Ling Yui Holdings Limited is a company incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange under stock code 784. Detailed information on its industry and core business is not provided in the announcement, which focuses instead on corporate actions related to its shareholding and control.
Average Trading Volume: 11,595,510
Technical Sentiment Signal: Buy
Current Market Cap: HK$744M
For a thorough assessment of 0784 stock, go to TipRanks’ Stock Analysis page.